Connecting HIV‐1 integration and transcription: a step toward new treatments
- 16 June 2016
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 590 (13) , 1927-1939
Abstract
Thanks to the current combined antiretroviral therapy (cART), HIV‐1 infection has become a manageable although chronic disease. The reason for this lies in the fact that long‐lived cellular reservoirs persist in patients on cART. Despite numerous efforts to understand molecular mechanisms that contribute to viral latency, the important question of how and when latency is established remains unanswered. Related to this is the connection between HIV‐1 integration and the capacity of the provirus to enter the latent state. In this review, we will give an overview of these nuclear events in the viral life cycle in the light of current therapeutic approaches, which aim to either reactivate the provirus or even excise the proviral DNA from the cellular genome.Keywords
Funding Information
- Deutsches Zentrum für Infektionsforschung
This publication has 130 references indexed in Scilit:
- Reactivation of Latent HIV-1 by Inhibition of BRD4Cell Reports, 2012
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus ReactivationImmunity, 2012
- The Control of HIV Transcription: Keeping RNA Polymerase II on TrackCell Host & Microbe, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivoNature Biotechnology, 2010
- Transcriptional Bursting from the HIV-1 Promoter Is a Significant Source of Stochastic Noise in HIV-1 Gene ExpressionBiophysical Journal, 2010
- LEDGF Hybrids Efficiently Retarget Lentiviral Integration Into HeterochromatinMolecular Therapy, 2010
- Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 ReplicationCell, 2008
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleasesNature Biotechnology, 2008